Engaging Stakeholders to Promote Safe Anesthesia and Sedation Care in Young Children

Area of Science:

• Neuroscience
• Anesthesiology
• Public Health

Background:

• Pediatric anesthetic neurotoxicity research requires enhanced collaboration among diverse stakeholders.
• Effective engagement strategies are vital for accelerating scientific progress and knowledge dissemination.
• The Pediatric Anesthesia Neurodevelopment Assessment (PANDA) symposium serves as a platform for discussing these challenges.

Purpose of the Study:

• To summarize discussions from the 2018 PANDA symposium on novel stakeholder engagement methods.
• To explore perspectives from government agencies, pharmaceutical companies, research communities, and patients.
• To identify successful and attempted strategies for improving research collaboration.

Main Methods:

• Summary of a round table discussion held at the 2018 PANDA symposium.
• Review of presented topics including online patient portals, public-private partnerships, and agency initiatives.
• Incorporation of first-hand experiences from various stakeholders.

Main Results:

• Initiatives like online patient portals and public-private partnerships show promise for engagement.
• Government agencies such as the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) are actively working to improve research engagement and dissemination.
• The discussion highlighted practical insights and shared experiences in stakeholder engagement.

Conclusions:

• Improving stakeholder engagement is critical for advancing pediatric anesthetic neurotoxicity research.
• Multi-faceted approaches involving patients, government, industry, and researchers are necessary.
• The PANDA symposium provides a valuable forum for sharing strategies and fostering collaboration.